Thompson Jon S, Gilroy Richard, Sudan Debra
Department of Surgery (General Surgery and Transplant Surgery), University of Nebraska Medical Center, 983280, Nebraska Medical Center, Omaha, NE 68198-3280, USA.
J Gastrointest Surg. 2008 Jan;12(1):73-6. doi: 10.1007/s11605-007-0375-9. Epub 2007 Oct 30.
The short bowel syndrome (SBS) can result from a variety of conditions, including postoperative complications and malignancy. Continence-preserving operations are generally performed for either ulcerative colitis (UC) or familial polyposis (FAP). These procedures can be associated with high morbidity and the potential for future malignancy. Our aim was to determine the causes and consequences of SBS in patients undergoing these procedures. Twenty-four patients (12 men and 12 women) 18 to 64 years of age were identified with SBS after continence-preserving procedures. Eighteen had pelvic procedures, and six had continent ileostomies. All SBS patients had a proximal ostomy. Remnant length measured <60 cm in five patients, 60-120 cm in ten patients, and >120 cm in nine patients. Overall 13 patients required long-term PN. Four FAP patients with desmoid tumors died. One patient with UC underwent intestinal transplant and expired. Follow-up ranges from 6 to 192 months. Overall 14 patients had UC, nine had FAP, and one had functional disease. Eight patients with an initial diagnosis of UC had subsequent Crohn's disease necessitating further resection and pouch excision. Eight patients (five with UC, two FAP, and one with functional disease) had postoperative complications, including obstruction or mesenteric ischemia requiring resections. One UC patient developed adenocarcinoma in a continent ileostomy. Seven of the nine FAP patients required resection for desmoid tumors. Six of these underwent resection alone. Three died at 10, 11, and 13 months after SBS from liver failure and sepsis while awaiting transplant. One patient has recurrent desmoid at 30 months, another is alive and well at 48 months, and the other patient, who was not a transplant candidate, died from an unrelated cardiac operation at 23 months. A single patient underwent resection with simultaneous multivisceral transplantation. SBS can develop after continence-preserving procedures. This occurs with inflammatory bowel disease when unsuspected Crohn's disease is present or complications occur. SBS related to desmoid tumors has a poor prognosis in patients undergoing resection alone. A more aggressive approach to intestinal transplantation in these patients may be warranted.
短肠综合征(SBS)可由多种情况引起,包括术后并发症和恶性肿瘤。保留控便功能的手术通常针对溃疡性结肠炎(UC)或家族性腺瘤性息肉病(FAP)进行。这些手术可能伴随着高发病率以及未来发生恶性肿瘤的可能性。我们的目的是确定接受这些手术的患者发生SBS的原因及后果。24例年龄在18至64岁之间的患者(12名男性和12名女性)在接受保留控便功能的手术后被诊断为SBS。18例接受盆腔手术,6例接受可控性回肠造口术。所有SBS患者均有近端造口。5例患者的残余肠段长度<60 cm,10例患者为60 - 120 cm,9例患者>120 cm。总体而言,13例患者需要长期肠外营养(PN)。4例患有硬纤维瘤的FAP患者死亡。1例UC患者接受了肠道移植,最终死亡。随访时间为6至192个月。总体而言,14例患者患有UC,9例患有FAP,1例患有功能性疾病。8例最初诊断为UC的患者随后发生克罗恩病,需要进一步切除和切除贮袋。8例患者(5例UC患者、2例FAP患者和1例功能性疾病患者)出现术后并发症,包括肠梗阻或肠系膜缺血,需要进行切除术。1例UC患者在可控性回肠造口处发生腺癌。9例FAP患者中有7例因硬纤维瘤需要进行切除术。其中6例仅接受了切除术。3例患者在SBS发生后10、11和13个月时,因肝衰竭和败血症在等待移植期间死亡。1例患者在3个月时硬纤维瘤复发,另1例在48个月时存活且情况良好,还有1例患者因不符合移植条件,在23个月时死于一场无关的心脏手术。1例患者接受了联合多脏器移植切除术。保留控便功能的手术后可能会发生SBS。当存在未被怀疑的克罗恩病或出现并发症时,炎症性肠病患者会出现这种情况。对于仅接受切除术的患者,与硬纤维瘤相关的SBS预后较差。在这些患者中,可能需要采取更积极的肠道移植方法。